In brief
- Hepatitis B and C are blood-borne viral infections that spread by blood, sexual contact and from mother to child. They are the main cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma worldwide, and are kept going by a large pool of chronic carriers.
- Key to the epidemiology: carriers are the main source; hepatitis B can be prevented by vaccine (birth dose, plus immunoglobulin for babies of infected mothers); hepatitis C has no vaccine and no immunity after infection, so prevention rests on safe injection, harm reduction and screening.
- Key to control: treat to cut infectivity and cure (topic 15), vaccinate the susceptible, give post-exposure prophylaxis for hepatitis B, test and notify, and aim for WHO 2030 elimination targets.
Agents
Hepatitis B virus (HBV)
- Hepadnaviridae; a partly double-stranded DNA virus that replicates through an RNA intermediate with a reverse transcriptase. Genotypes A-J; genotype D is common in Bulgaria and around the Mediterranean.
- Very stable outside the body: infectious on surfaces for at least 7 days, which explains spread through minute blood contamination.
- Infectivity markers: HBsAg (surface antigen), HBeAg and HBV DNA.
Hepatitis C virus (HCV)
- Flaviviridae, genus Hepacivirus; an RNA virus with 8 genotypes. Genotype 1b predominates in Bulgaria and Eastern Europe; 3a is common among people who inject drugs.
- High genetic variability (quasispecies) means no vaccine and no protective immunity: reinfection is possible after cure.
Hepatitis D virus (HDV)
- A defective RNA virus that needs HBsAg to make its envelope; it exists only together with HBV.
Hepatitis B virions (Dane particles) and the smaller filamentous and spherical surface-antigen particles.
Image: “Hepatitis-B virions” by CDC, Public domain, via Wikimedia Commons.